[Federal Register Volume 63, Number 124 (Monday, June 29, 1998)]
[Notices]
[Page 35243]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17175]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.

    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Cancer Institute Special Emphasis 
Panel Epidemiologic Studies of the Mayak and Techa River Cohorts.
    Date: July 10, 1998.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Executive Plaza North--Conference Room D, 6130 Executive 
Boulevard, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: C.M. Kerwin, Phd, Scientific Review 
Administrator, Special Review, Referral and Resources Branch, 
Division of Extramural Affairs, National Cancer Institute, National 
Institutes of Health, 6130 Executive Boulevard/EPN-609, Rockville, 
MD 20892-7405, 301/496-7421.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Phase I Clinical Studies of Chemopreventive Agents.
    Date: July 13, 1998.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Executive Plaza North--Conference Room F, 6130 Executive 
Blvd., Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: C.M. Kerwin, Phd, Scientific Review 
Administrator, Special Review, Referral and Resources Branch, 
Division of Extramural Affairs, National Cancer Institute, National 
Institutes of Health, 6130 Executive Boulevard/EPN-609, Rockville, 
MD 20892-7405, 301/496-7421.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel International Phase III IL-2 Study.
    Date: July 17, 1998.
    Time: 7:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Olivia A. Preble, Phd, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6130 Executive Boulevard--Rm. 643, Rockville, MD 20892-7405, 
301/496-7929.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 23, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-17175 Filed 6-26-98; 8:45 am]
BILLING CODE 4140-01-M